On April 23, Christine Clark, owner of Premium Drug Screening, Shelton, Washington, was sentenced in U.S. District Court, Tacoma, Washington, to 3 years’ probation, a $100 assessment fee, and 100 hours of community service. She will be monitored with an active GPS and restricted to her residence for 270 days. In December 2017, she pleaded guilty to mail fraud related to a scheme to defraud companies that hired her to administer their DOT drug-testing programs.
The investigation revealed that Clark was supposed to collect urine specimens from employees and ship them to certified laboratories for testing. Instead, she fabricated DOT drug-test reports to make it appear the urine specimens had been tested by a certified lab when they had not been tested at all. Between 2009 and 2015, only 94 of the 592 samples collected by Clark were tested by laboratories. The companies used the fabricated reports to satisfy DOT’s drug-testing requirements, and their employees drove school buses, transit buses, and other commercial motor vehicles in western Washington.
DOT-OIG conducted this investigation with assistance from the Federal Motor Carrier Safety Administration (FMCSA) and the Washington State Patrol.